News Home

How Risky is Nabriva Therapeutics PLC - ADR (NBRV) Stock?

Monday, December 07, 2020 08:13 AM | InvestorsObserver Analysts
How Risky is Nabriva Therapeutics PLC - ADR (NBRV) Stock?

Nabriva Therapeutics PLC - ADR (NBRV) is down -1.86% today.

Overall Score - 34
NBRV has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on NBRV!
NBRV stock originally closed yesterday at $3.77 and is up $0.12 so far during pre-market trading. Pre-market tends to hold more volatility due to significantly less volume as most investors only trade between standard trading hours.

NBRV has a roughly avereage overall score of 34 meaning the stock holds a better value than 34% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock.

NBRV currently holds a average Short-Term Technical score of 0 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month has been bearish. Nabriva Therapeutics PLC - ADR currently has the 90th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders.

Nabriva Therapeutics PLC - ADR's Overall and Short-Term Technical score paint a poor picture for NBRV's recent trading patterns and forecasted price.

Click Here to get the full Stock Score Report on Nabriva Therapeutics PLC - ADR (NBRV) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App